Search research articles
Contact Us
Filters
Showing results (231-240 of 269) with videos related to
Page
of 27
Sort By:
Frontiers in Oncology
|
September 12, 2022
MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
Cynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Amy Liu, et al.
The New Phytologist
|
January 3, 2018
The BIG protein distinguishes the process of CO<sub>2</sub> -induced stomatal closure from the inhibition of stomatal opening by CO<sub>2</sub>
Jingjing He, Ruo-Xi Zhang, Kai Peng, et al.
Brachytherapy
|
December 17, 2022
Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy
Aba Anoa Scott, Madrigal Weersink, Zhihui Amy Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 5, 2022
Recommended first-line management of brain metastases from melanoma: A multicenter survey of clinical practice
Paola Anna Jablonska, Chin Heng Fong, Timothy Kruser, et al.
Diseases of the Colon and Rectum
|
January 24, 2022
Impact of Definitive Chemoradiation on Quality-of-Life Changes for Patients With Anal Cancer: Long-term Results of a Prospective Study
Ali Hosni, Jolie Ringash, Kathy Han, et al.
Hepatology (Baltimore, Md.)
|
March 13, 2019
Collagen Formation Assessed by N-Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography
Cyrielle Caussy, Meera Bhargava, Ida F Villesen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 24, 2026
Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes
John Mohan Mathew, Hannah Bacon, Jeff Winter, et al.
Cell Reports
|
August 28, 2025
T cell receptor repertoire in cell-free DNA as a proxy for tumor infiltrates in patients treated with pembrolizumab
Shirin Soleimani, Xuan Li, Ben X Wang, et al.
Clinical and Translational Radiation Oncology
|
December 11, 2025
Impact of excluding internal mammary node coverage on musculoskeletal dosimetry in breast radiotherapy
Stephen Lowell Ciocon, Antonio de la Pena Villarreal, Grace Lee, et al.
JAMA Network Open
|
June 6, 2024
COVID-19 Vaccination Coverage and Factors Associated With Vaccine Uptake Among People With HIV
Rulin C Hechter, Lei Qian, In-Lu Amy Liu, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 269) with videos related to
Sort By:
Page
of 27
Frontiers in Oncology
|
September 12, 2022
MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
Cynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Amy Liu, et al.
The New Phytologist
|
January 3, 2018
The BIG protein distinguishes the process of CO<sub>2</sub> -induced stomatal closure from the inhibition of stomatal opening by CO<sub>2</sub>
Jingjing He, Ruo-Xi Zhang, Kai Peng, et al.
Brachytherapy
|
December 17, 2022
Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy
Aba Anoa Scott, Madrigal Weersink, Zhihui Amy Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 5, 2022
Recommended first-line management of brain metastases from melanoma: A multicenter survey of clinical practice
Paola Anna Jablonska, Chin Heng Fong, Timothy Kruser, et al.
Diseases of the Colon and Rectum
|
January 24, 2022
Impact of Definitive Chemoradiation on Quality-of-Life Changes for Patients With Anal Cancer: Long-term Results of a Prospective Study
Ali Hosni, Jolie Ringash, Kathy Han, et al.
Hepatology (Baltimore, Md.)
|
March 13, 2019
Collagen Formation Assessed by N-Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography
Cyrielle Caussy, Meera Bhargava, Ida F Villesen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 24, 2026
Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes
John Mohan Mathew, Hannah Bacon, Jeff Winter, et al.
Cell Reports
|
August 28, 2025
T cell receptor repertoire in cell-free DNA as a proxy for tumor infiltrates in patients treated with pembrolizumab
Shirin Soleimani, Xuan Li, Ben X Wang, et al.
Clinical and Translational Radiation Oncology
|
December 11, 2025
Impact of excluding internal mammary node coverage on musculoskeletal dosimetry in breast radiotherapy
Stephen Lowell Ciocon, Antonio de la Pena Villarreal, Grace Lee, et al.
JAMA Network Open
|
June 6, 2024
COVID-19 Vaccination Coverage and Factors Associated With Vaccine Uptake Among People With HIV
Rulin C Hechter, Lei Qian, In-Lu Amy Liu, et al.
Page
of 27